Savvy Advisors Inc’s Novo Nordisk NVO Stock Holding History

Savvy Advisors Inc’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.28M	Buy	34,795 +1,468	+4%	+$69.6K	0.03%	368
2025 Q4	$1.7M	Sell	33,327 -15,497	-32%	-$792K	0.05%	260
2025 Q3	$2.71M	Buy	48,824 +22,138	+83%	+$1.3M	0.12%	120
2025 Q2	$1.84M	Buy	26,686 +14,672	+122%	+$998K	0.12%	126
2025 Q1	$834K	Buy	12,014 +4,891	+69%	+$404K	0.08%	196
2024 Q4	$613K	Buy	7,123 +3,395	+91%	+$367K	0.07%	215
2024 Q3	$444K	Buy	3,728 +1,524	+69%	+$203K	0.09%	196
2024 Q2	$315K	Buy	+2,204	New	+$292K	0.1%	203

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Savvy Advisors Inc's NVO Position: Q1 2026 in Review

Savvy Advisors Inc increased its Novo Nordisk (NVO) stake by 4.4% in Q1 2026, buying an estimated $69.6K and bringing the position to 34,795 shares worth $1.28M. The position accounts for 0.03% of the portfolio, ranked #368.

Savvy Advisors Inc first reported a position in NVO in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.71M in Q3 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Savvy Advisors Inc held 34,795 shares of Novo Nordisk worth $1.28M as of Q1 2026.
Savvy Advisors Inc bought 1,468 Novo Nordisk shares in Q1 2026, an estimated $69.6K.
Novo Nordisk made up 0.03% of Savvy Advisors Inc's portfolio in Q1 2026, its #368 holding.
Savvy Advisors Inc first reported a position in Novo Nordisk in Q2 2024 and has held it in 8 quarters since.
Savvy Advisors Inc's Novo Nordisk position peaked at $2.71M in Q3 2025.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Savvy Advisors Inc's 13F filing for Q1 2026, filed 11 May 2026.